Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIMSPRO in Diffuse Cutaneous Systemic Sclerosis
2007-003122-24Phase 2Completed
- Sponsor
- Daval International Ltd
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing AIMSPRO with Placebo (2 arms). Primary endpoint: Safety and tolerability of AIMSPRO. Started Feb 2008; status: completed.
02
Drugs
hyperimmune caprine serum against hiv lysate
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2007-003122-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003122-24.